These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8559351)

  • 1. Rapidly growing histologically benign meningiomas: cell kinetic and deoxyribonucleic acid ploidy features: report of three cases.
    Kudoh C; Sugiura K; Yoshimizu N; Detta A
    Neurosurgery; 1995 Nov; 37(5):998-1000; discussion 1000-1. PubMed ID: 8559351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma.
    Myong NH; Chi JG
    J Korean Med Sci; 1997 Jun; 12(3):221-7. PubMed ID: 9250918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index.
    Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
    Neurol Med Chir (Tokyo); 1995 May; 35(5):289-93. PubMed ID: 7623949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningioma: proliferating potential and clinicoradiological features.
    Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
    Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive meningioma: a tumour with high proliferating and "recurrence" potential.
    Suwa T; Kawano N; Oka H; Ito H; Kameya T
    Acta Neurochir (Wien); 1995; 136(3-4):127-31. PubMed ID: 8748841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA analysis of meningiomas using paraffin-embedded surgical specimens in connection with clinical recurrence].
    Akachi K; Matsumoto M; Yasue M; Nakamura N; Kamada M; Ohno T
    No Shinkei Geka; 1991 Dec; 19(12):1129-34. PubMed ID: 1766537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
    J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical study of progesterone receptor in human meningioma.
    Perrot-Applanat M; Groyer-Picard MT; Kujas M
    Acta Neurochir (Wien); 1992; 115(1-2):20-30. PubMed ID: 1595392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy and cell-cycle analysis in intracranial meningiomas and hemangiopericytomas: a study with high-resolution DNA flow cytometry.
    Zellner A; Meixensberger J; Roggendorf W; Janka M; Hoehn H; Roosen K
    Int J Cancer; 1998 Apr; 79(2):116-20. PubMed ID: 9583723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of nuclear DNA content in human meningiomas: a prospective study.
    Meixensberger J; Janka M; Zellner A; Roggendorf W; Roosen K
    Acta Neurochir Suppl; 1996; 65():70-2. PubMed ID: 8738500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA in meningioma tissues and explant cell cultures. A flow cytometric study with clinicopathological correlates.
    Ironside JW; Battersby RD; Lawry J; Loomes RS; Day CA; Timperley WR
    J Neurosurg; 1987 Apr; 66(4):588-94. PubMed ID: 3559726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
    Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
    Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferative activity of meningiomas as evaluated by bromodeoxyuridine uptake examination.
    Fukui M; Iwaki T; Sawa H; Inoue T; Takeshita I; Kitamura K
    Acta Neurochir (Wien); 1986; 81(3-4):135-41. PubMed ID: 3529838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
    Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
    Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic indicators.
    Sarkar A; Chiocca EA
    J Neurosurg; 2006 Aug; 105(2):161-2; discussion 162. PubMed ID: 17219817
    [No Abstract]   [Full Text] [Related]  

  • 16. Cystic meningioma: report of three patients.
    Odake G
    Neurosurgery; 1992 Jun; 30(6):935-40. PubMed ID: 1614600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Grade zero removal of supratentorial convexity meningiomas.
    Perry JR; Cusimano MD
    Neurosurgery; 1994 Apr; 34(4):770-1; author reply 771. PubMed ID: 8054050
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors.
    Salmon I; Kiss R; Levivier M; Remmelink M; Pasteels JL; Brotchi J; Flament-Durand J
    Am J Surg Pathol; 1993 Mar; 17(3):239-47. PubMed ID: 8434704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pericytosis and edema generation: a unique clinicopathological variant of meningioma.
    Robinson JC; Challa VR; Jones DS; Kelly DL
    Neurosurgery; 1996 Oct; 39(4):700-6; discussion 706-7. PubMed ID: 8880761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningioma.
    Kujas M
    Curr Opin Neurol; 1993 Dec; 6(6):882-7. PubMed ID: 8293162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.